Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Serious risks include potential thyroid C-cell tumors (Zepbound is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2), acute pancreatitis, gallbladder disease, and hypoglycemia when used with insulin or insulin secretagogues
Results Both semaglutide and tirzepatide offer gradual results
12 mg group: 24.1%
Would another therapy be more appropriate
Many patients prioritize protein exclusively, which can worsen constipationa common side effect of GLP-1 medications
US$ 23.15
US$ 29.37
US$ 28.48
US$ 26.41
